Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems

被引:11
|
作者
Akturk, Halis K. [1 ]
Battelino, Tadej [2 ,3 ]
Castaneda, Javier [4 ]
Arrieta, Arcelia [4 ]
van den Heuvel, Tim [4 ]
Cohen, Ohad [4 ]
机构
[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[4] Medtron Int Trading Sarl, Route Molliau 31, CH-1131 Tolochenaz, Switzerland
关键词
Automated insulin delivery; Time in tight range; Insulin therapy; Closed-loop; Insulin pump; MiniMed (TM); Glucose control; INTERNATIONAL CONSENSUS; DIABETIC-RETINOPATHY; METRICS; COMPLICATIONS; ASSOCIATION; INITIATION;
D O I
10.1089/dia.2023.0432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concept of maintaining blood glucose levels within the 70-180 mg/dL range, known as time-in-range, has raised questions regarding its representation of true physiological euglycemia. Some have speculated that focusing on the time spent within the 70-140 mg/dL range, introduced as time in tight range (TITR) through the International Consensus statement, could serve as a more precise metric for assessing normoglycemia in individuals with type 1 diabetes. This article delves into the current status of TITR as an emerging marker and explores how advanced hybrid closed-loop systems may offer a promising avenue for achieving this higher level of glycemic control.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 50 条
  • [41] Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
    Okabayashi, Takehiro
    Shima, Yasuo
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (02): : 190 - 199
  • [42] Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece
    Lambadiari, Vaia
    Saltik, Asli Zeynep Ozdemir
    de Portu, Simona
    Buompensiere, Maria Ida
    Kountouri, Aikaterini
    Korakas, Emmanouil
    Sharland, Helen
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (05) : 316 - 323
  • [43] Efficacy of open-source automated insulin delivery systems compared with commercial hybrid closed-loop insulin pumps: real-world data from a tertiary center
    Horvath, L.
    Mraz, M.
    Klouckova, J.
    Vavra, D.
    Bem, R.
    Haluzik, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S386 - S387
  • [44] Glycaemic outcomes and the importance of active insulin time in the Pivotal trial of the MiniMed™ Advanced Hybrid Closed-Loop (AHCL) system
    Carlson, A.
    Bode, B.
    Christiansen, M.
    Garg, S.
    Kaiserman, K.
    Kipnes, M.
    Liljenquist, D.
    Philis-Tsimikas, A.
    Pop-Busui, R.
    Reed, J.
    Sherr, J.
    Shulman, D.
    Slover, R.
    Thrasher, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S86 - S86
  • [45] TWO CASES OF HYBRID CLOSED-LOOP INSULIN DELIVERY IN T1DM PREGNANCY
    Naderpoor, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A122 - A122
  • [46] Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems
    Turner, Lauren V.
    Riddell, Michael C.
    DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2492 - 2496
  • [47] Successful hybrid closed-loop insulin delivery in type 1 diabetes and Addison's disease
    Josipovic, M.
    Davenport, K.
    Hartnell, S.
    Donald, S.
    Evans, M. L.
    DIABETIC MEDICINE, 2020, 37 : 83 - 83
  • [48] Cognitive function in T1DM improved by hybrid closed-loop insulin delivery
    Tysoe O.
    Nature Reviews Endocrinology, 2022, 18 (11) : 657 - 657
  • [49] Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
    Dovc, Klemen
    Boughton, Charlotte
    Tauschmann, Martin
    Thabit, Hood
    Bally, Lia
    Allen, Janet M.
    Acerini, Carlo L.
    Arnolds, Sabine
    de Beaufort, Carine
    Bergenstal, Richard M.
    Campbell, Fiona
    Criego, Amy
    Dunger, David B.
    Elleri, Daniella
    Evans, Mark L.
    Froehlich-Reiterer, Elke
    Hofer, Sabine
    Kapellen, Thomas
    Leelarathna, Lalantha
    Pieber, Thomas R.
    Rami-Merhar, Birgit
    Shah, Viral N.
    Sibayan, Judy
    Wilinska, Malgorzata E.
    Hovorka, Roman
    DIABETES CARE, 2019, 42 (07) : 1344 - 1347
  • [50] TIME SPENT IN HYPOGLYCAEMIA ACCORDING TO AGE AND TIME OF DAY: OBSERVATIONS DURING CLOSED-LOOP INSULIN DELIVERY
    Alwan, H.
    Ware, J.
    Wilinska, M.
    Boughton, C.
    Allen, J.
    Lakshman, R.
    Nwokolo, M.
    Hartnell, S.
    Bally, L.
    De Beaufort, C.
    Besser, R.
    Campbell, F.
    Evans, M.
    Frohlich-Reiterer, E.
    Ghatak, A.
    Hofer, S.
    Kapellen, T.
    Leelarathna, L.
    Mader, J.
    Narendran, P.
    Rami-Mehrar, B.
    Thabit, H.
    Thankamony, A.
    Denvir, L.
    Davis, N.
    Hovorka, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A134 - A134